We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Hyperpolarizer Enables Users to Double Polarization Levels for MR Imaging of Lungs

By MedImaging International staff writers
Posted on 28 Jan 2015
Print article
New technology has been devised to generate hyperpolarized inert xenon gas, which is used in conjunction with standard magnetic resonance imaging (MRI) to create high resolution three-dimensional (3D) images of the human lung. This technique is a novel way to track extremely small changes in lung structure and lung function, and is used in basic and clinical research to study lung physiology and to monitor the efficacy of new drugs.

Polarean, Inc. (Durham, NC, USA), a developer of hyperpolarized gas technology, devised the new system to greatly enhance polarization rates. The new technology is now being offered as an upgrade kit to current owners of 9800 series Polarean xenon hyperpolarizers, enabling them to consistently reach polarization levels of 20%–25%. Further polarization enhancements are underway, to be included in the new 9820 Series of Polarean hyperpolarizers, available in mid-2015.

Polarean’s hyperpolarization technology addresses a significant need in pulmonary research and drug development. Higher levels of polarization provide researchers with additional flexibility. They can decrease the amount of xenon to be inhaled, without compromising image quality, and this is especially important in pediatric studies. Or, researchers can use the same amount of xenon and achieve higher image quality.

“We have made significant improvements in our hyperpolarization technology, especially in the downstream recovery of polarized xenon,” commented Dr. Bastiaan Driehuys, Polarean’s founder and chief scientific officer. “In addition, Polarean is developing a new generation of polarizers that not only include these downstream improvements, but also new optical cell designs and a more powerful laser. Together, these improvements will take our polarization and production levels even higher.”

Polarean expects to launch this new line of hyperpolarizers in mid-2015. Polarean’s research equipment is currently in use at leading academic research centers in North America and Europe.

Polarean, Inc. began operations in 2012, after securing all assets and intellectual property for hyperpolarized gas MRI from GE Healthcare (Chalfont St. Giles, UK). Polarean designs and manufactures equipment for production of hyperpolarized xenon or helium gases. When used in conjunction with MRI, these gases offer an essentially new and noninvasive functional imaging platform. Current research uses include early diagnosis of respiratory diseases as well as monitoring progression and therapeutic response. Moreover, xenon gas exhibits solubility and signal properties that enable it to be imaged within other tissues and organs as well. Polarean hyperpolarization systems are currently sold in the United States and internationally for research and investigational applications only.

The central equipment required for hyperpolarized gas MRI is a polarizer. Using circularly polarized laser light, the polarizer transforms the inert, stable noble gas isotopes 3He and 129Xe into their hyperpolarized states. This process leaves the gases chemically unaltered, while their nuclei are magnetically aligned. The resulting MRI signal is enhanced by a factor of 100,000, making direct imaging of gas molecules possible.

Related Links:

Polarean




Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
P25 Elite
Laptop Ultrasound Scanner
PL-3018
Digital Radiography Acquisition Software
VXvue with PureImpact

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.